Cardiac Structure, Function, and Clinical Manifestations in MINOCA

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Acute Coronary SyndromeMyocardial Infarction
Interventions
OTHER

Integrative characterization of MINOCA patients

"Characterization of MINOCA patients will be based on integrative evaluation of imaging data, blood levels of proinflammatory and anti-inflammatory cytokines, and genetic testing for thrombophilia risk.~MSCT: Imaging for the presence and vulnerability of coronary plaque as well as plaque disruption.~CMR: Imaging for identification of myocardial injury (late gadolinium enhancement and myocardial edema) as well as other concomitant findings.~SPECT: Single-Photon Emission Computed Tomography enable assessment of myocardial perfusion and viability.~Blood tests.~Genetic tests."

OTHER

Characterization of MI patients with coronary obstruction

"Characterization of patients with myocardial infarction and obstructive atherosclerosis will be based on integrative evaluation of imaging data, blood levels of proinflammatory and anti-inflammatory cytokines, and genetic testing for thrombophilia risk.~MSCT: Imaging for the presence and vulnerability of coronary plaque as well as plaque disruption.~CMR: Imaging for identification of myocardial injury (late gadolinium enhancement and myocardial edema) as well as other concomitant findings.~SPECT: Single-Photon Emission Computed Tomography enable assessment of myocardial perfusion and viability.~Blood tests.~Genetic tests."

Trial Locations (1)

634012

Vyacheslav Ryabov, Tomsk

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT03572023 - Cardiac Structure, Function, and Clinical Manifestations in MINOCA | Biotech Hunter | Biotech Hunter